openPR Logo
Press release

Covid-19 Updates : Ebola Virus Infection Drug Market Revenue Analysis | Global Players - Merck & Co.,  NewLink Genetics Corporation, Johnson & Johnson 

06-30-2020 05:26 PM CET | Health & Medicine

Press release from: Data Bridge Market Research Pvt. Ltd.

Ebola Virus Infection Drug Market

Ebola Virus Infection Drug Market

Today’s businesses call for the highly focused, comprehensive and detail-oriented information about the market so that they get a clear idea about the market landscape. The Ebola Virus Infection Drug market research report is generated with a combination of detailed industry insights, and use of latest tools and technology. The study of this market research report covers a market attractiveness analysis, wherein each segment is targeted based on its market size, growth rate & general attractiveness. The Ebola Virus Infection Drug market research report plays a key role in developing the strategies for sales, advertising, marketing, and promotion.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ebola-virus-infection-drug-market

Not to mention, the data included in this Ebola Virus Infection Drug market document is collected only from the trustworthy sources such as journals, newspapers, company websites and annual reports of the companies on which businesses can rely confidently. Other data models used for the research methodology are vendor positioning grid, market time line analysis, market overview & guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis & vendor share analysis. The studies related to competitor analysis in this Ebola Virus Infection Drug market document keeps competitive landscape clearly into focus with which businesses can decide or advance their own strategies to thrive in the market.

Global Ebola virus infection drug market is rising with a substantial CAGR in the forecasted period of 2019-2026. This rise in market can be attributed to the increasing number of Ebola virus infected patients , growing prevalence of Ebola virus infections, the lack of a reliable cure for Ebola virus infections and steady government support to Ebola research, developing Ebola drugs and vaccines.

Few of the major competitors currently working in the global Ebola virus infection drug market are Merck & Co., Inc,  NewLink Genetics Corporation, Johnson & Johnson Private Limited , GlaxoSmithKline plc, Novavax, GeoVax, Mapp Biopharmaceutical, Arbutus Biopharma,  Bavarian Nordic , Nanoviricides, INC, Sarepta Therapeutics, Chimerix, Biocryst Pharmaceuticals, INC, Hemispherx Biopharma, Inc, BioComo Incorporation, Peptineo, Bio-Excel, Geneone Life Sciences, IMV Inc, Etubics.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-ebola-virus-infection-drug-market

Market Definition: Global Ebola Virus Infection Drug Market

Ebola virus infection is a serious fatal condition which is caused by the four different species of Ebola virus in humans and non-human primates. It causes hemorrhagic fever which leads to internal and external bleeding and affects multiple organs. A person with Ebola virus infection at initial stage experiences sore throat, muscular pain, headaches. Vomiting, rashes and diarrhea at later stages along with decreased function of kidney and liver. At this stage some patients begin to bleed internally as well as externally. This infection has about average 50.0% of high risk of deaths.

According to WHO report dated 26 December 2018, a total of 591 Ebola virus infected cases, including 543 confirmed and 48 probable cases, have been reported from 16 health zones in the two neighboring provinces of North Kivu and Ituri. Of these cases, 54 were healthcare workers, of which 18 died. Overall, 357 cases have died (case fatality ratio 60.0%). In the past week, ten additional patients were discharged from Ebola treatment center overall, 203 patients have recovered to date. The highest number of cases was from age group 15‒49 years with 60.0% (355/589) of the cases, and of those, 228 were female. Peak attack rates have been detected in children aged more than one year (especially male infants) and females aged 15 years and older.

Key Developments in the Ebola Virus Infection Drug Market:

In March 2015, ChAd3-ZEBOV vaccine is developed by GlaxoSmithKline plc in collaboration with the US National Institute of Allergy and Infectious Diseases (NIAID) is under phase II/III of clinical trial and shows 90.0% efficacy rate, and the safety of vaccine and placebo is high.

In April 2015, VSV-EBOV vaccine is developed by NewLink Genetics and Merck & Co., Inc. in collaboration with the Public Health Agency of Canada is under phase III of clinical trial and currently in use and shows very high efficacy rate and the vaccine regimen appears to be well tolerated by adult volunteers.

Segmentation: Global Ebola Virus Infection Drug Market

Ebola Virus Infection Drug Market : By Strain Type

Zaire
Sudan
Tai forest
Bundibugyo virus

Ebola Virus Infection Drug Market : Novel Drug Type

Zmapp
Favipiravir
GS-5734
TKM-Ebola
AVI-7537

Ebola Virus Infection Drug Market : Vaccine Type

cad3-ZEBOV
rvsv-ZEBOV

Ebola Virus Infection Drug Market : Route of Administration

Oral
Intravenous
Others

Ebola Virus Infection Drug Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

Ebola Virus Infection Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Ebola Virus Infection Drug Market Restraints :

The unpredictable nature of Ebola has slow down research efforts
Unavailability of effective treatment
Lack of awareness among the patient and physician about chronic obstructive pulmonary disease treatment

Ebola Virus Infection Drug Market Drivers :

Increasing number of Ebola virus infected patients
Growing prevalence of Ebola virus infections around the world
Increasing awareness about the infection
Lack of a reliable cure for Ebola virus infections
Steady government support for Ebola research including development of Ebola drugs and vaccines

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ebola-virus-infection-drug-market

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Covid-19 Updates : Ebola Virus Infection Drug Market Revenue Analysis | Global Players - Merck & Co.,  NewLink Genetics Corporation, Johnson & Johnson  here

News-ID: 2082391 • Views: 291

More Releases from Data Bridge Market Research Pvt. Ltd.

Temporal Arteritis Market 2020 Moving Towards Brighter Future | Major Giants – …
This Temporal Arteritis Market analysis report encompasses the growth factors of the worldwide market based on end-users. Also, the industry changing factors for the market segments are explored in this report. The report forecasts the innovative applications of the product market on the basis of several estimations. The Temporal Arteritis Market business report explains the growing popularity of the market competition by leading manufacturers or players, with sales volume, revenue
Vinblastine Sulfate Market 2020 Moving Towards Brighter Future | Major Giants …
This Vinblastine Sulfate Market analysis report encompasses the growth factors of the worldwide market based on end-users. Also, the industry changing factors for the market segments are explored in this report. The report forecasts the innovative applications of the product market on the basis of several estimations. The Vinblastine Sulfate Market business report explains the growing popularity of the market competition by leading manufacturers or players, with sales volume, revenue
Pediatric Drugs Market 2020 Moving Towards Brighter Future | Major Giants – Jo …
This Pediatric Drugs Market analysis report encompasses the growth factors of the worldwide market based on end-users. Also, the industry changing factors for the market segments are explored in this report. The report forecasts the innovative applications of the product market on the basis of several estimations. The Pediatric Drugs Market business report explains the growing popularity of the market competition by leading manufacturers or players, with sales volume, revenue
Erythropoietin Stimulating Agents Market 2020 Moving Towards Brighter Future | M …
This Erythropoietin Stimulating Agents Market analysis report encompasses the growth factors of the worldwide market based on end-users. Also, the industry changing factors for the market segments are explored in this report. The report forecasts the innovative applications of the product market on the basis of several estimations. The Erythropoietin Stimulating Agents Market business report explains the growing popularity of the market competition by leading manufacturers or players, with sales

All 5 Releases


More Releases for Ebola

Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus
Ebola Treatment Market: Global Industry Analysis and Forecast 2016 - 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,
2017-2022 Global Ebola Virus Vaccine Industry Forecast Report
ReportsWeb.com has announced the addition of the “Global Ebola Virus Vaccine Market Research Report 2017-2022” The report focuses on global major leading players with information such as company profiles, product picture and specification. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Ebola Virus Vaccine in these regions, from 2012 to 2022 (forecast) , covering North America, Europe,
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H1 2017, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape. Ebola is a rare but deadly viral infection that
Ebola Drug and Vaccine Market - Global Industry Analysis 2016 - 2024
Ebola has emerged as a major hazard to mankind in recent years. Though the Ebola virus and the disease caused by it have been familiar to science for decades, the risk of a global epidemic has increased massively due to the advances in globalization. The recent outbreak of Ebola in West Africa has brought the disease in the global spotlight. Ebola starts out as a sore throat, muscle pain, headache, and